Search Medical Condition
Please enter condition
Please choose location

Deafness Clinical Trials

A listing of Deafness medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (32) clinical trials

Examining the efficacy and safety trial of AM-111 (a gel that is injected), in the the treatment of subjects suffering from sudden hearing loss. This research study may be an option for you. Please see the eligibility criteria to see if you may qualify. Please reach out to our research ...

Phase

Implantation of the HiRes90K Advantage Cochlear Implant With HiFocus Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

The purpose of this feasibility study is to evaluate whether low-frequency acoustic hearing sensitivity can be preserved in newly implanted adults with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss) using the HiResolution™ 90K™ Advantage cochlear implant with the HiFocus™ Mid-Scala electrode to ...

Phase N/A

Cochlear Implantation in Cases of Single-Sided Deafness

Single-sided deafness (SSD) can be defined as moderate-to-profound sensorineural hearing loss with limited speech perception benefit in one ear and normal hearing in the contralateral ear. Though one ear is within the normal hearing limits, SSD may result in reduced speech perception in noise, variable abilities on localization tasks, increased ...

Phase N/A

Kineret CAPS Post Authorisation Study

A non-interventional, post authorization safety study to evaluate the safety of Kineret in the treatment of Cryopyrin Associated Periodic Syndromes (CAPS) in routine clinical care with regard to serious infections, malignancies, injection site reactions, allergic reactions and medication errors, including re-use of syringe.

Phase N/A

Multicenter Single-arm Study to Evaluate Efficacy Safety & Pharmacokinetics of Denosumab in Children w/ OI

To evaluate the effect of denosumab on lumbar spine bone mineral density(BMD) Z-score at 12 months, as assessed by dual-energy X-ray absorptiometry (DXA), inchildren 2 to 17 years of age with osteogenesis imperfecta.

Phase

Esteem New Subject Enrollment Post Approval Study

Purpose: To evaluate the long-term safety and efficacy of the Esteem Totally Implantable Hearing System (hereafter called Esteem) in subjects suffering from moderate to severe hearing loss. Questions: The following questions are to be answered: - Is Esteem effective through 1 year follow-up? - Is Esteem safe through 1 year ...

Phase N/A

Evaluating the Efficacy of Opti-Speech for Speech Treatment

Participants will be asked to complete the Goldman Fristoe Test of Articulation along with several other assessment tests. Then speech treatment, guided by Opti-Speech, will be provided to the participant for up to 10 treatment sessions. The participant will be asked to come back after the final treatment for a ...

Phase N/A

Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease

Alport Syndrome is an inherited disease that primarily affects the glomeruli, the tiny tufts of capillaries in the kidneys that filter wastes from the blood. The disease was first described by an English doctor named A. Cecil Alport. This disease is caused by changes in genes (mutations) that affect type ...

Phase N/A

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who meet conventional indications for implantation in one ear, but do not meet the conventional indications for implantation in the other ear (asymmetric hearing loss) using the HiResolution Bionic Ear System.

Phase N/A

Evaluation and Intervention for the Effects of Osteogenesis Imperfecta

We propose a longitudinal study of the natural history of types III and IV osteogenesis imperfecta for children age birth to 30 years. A consistent objective throughout this study is to obtain a comprehensive assessment of the natural history and progression of the multiple secondary features of osteogenesis imperfecta. In ...

Phase N/A